Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis

BACKGROUND: Hearing disorders are reported in thalassemia patients treated with deferoxamine. This study aimed to assess hearing loss in Iranian thalassemia major patients treated with deferoxamine. METHODS: This review article was designed based on PRISMA guidelines. To review the literature, two r...

Descripción completa

Detalles Bibliográficos
Autores principales: Badfar, Gholamreza, Mansouri, Akram, Shohani, Masoumeh, Karimi, Hamid, Khalighi, Zahra, Rahmati, Shoboo, Delpisheh, Ali, Veisani, Yousef, Soleymani, Ali, Azami, Milad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686301/
https://www.ncbi.nlm.nih.gov/pubmed/29201313
http://dx.doi.org/10.22088/cjim.8.4.239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686301/
https://www.ncbi.nlm.nih.gov/pubmed/29201313
http://dx.doi.org/10.22088/cjim.8.4.239

Ejemplares similares